Title Comparison between core needle biopsy and excisional biopsy for breast neoplasm
Authors Sun, Chunjie
Lu, Qun
Zhang, Xinrong
Zhang, Yuehong
Jia, Shuai
Wang, Jing
Zhu, Hailun
He, Wen
Zhang, Zhongqiu
Affiliation Tongzhou Maternal & Child Hlth Hosp Beijing, Dept Pathol, Beijing 101100, Peoples R China
Tongzhou Maternal & Child Hlth Hosp Beijing, Beijing, Peoples R China
Peking Univ, Reprod Med Ctr, Peoples Hosp, Beijing, Peoples R China
Tongzhou Maternal & Child Hlth Hosp Beijing, B Mode Ultrasonog, Beijing, Peoples R China
Tongzhou Maternal & Child Hlth Hosp Beijing, Dept Family Planning, Beijing, Peoples R China
Tongzhou Maternal & Child Hlth Hosp Beijing, Dept Galactophore, Beijing, Peoples R China
Keywords CANCER
DIAGNOSIS
ACCURACY
RECOMMENDATIONS
Issue Date 27-Aug-2021
Publisher MEDICINE
Abstract This study aimed to explore clinical significance of core needle biopsy (CNB) in pathological diagnosis of breast neoplasm. Seventy one breast neoplasm samples were obtained from Tongzhou Maternal and Child Health Hospital of Beijing between the years of 2006 and 2014. Forty five specimens were obtained via CNB and cases offering 26 of them received neoadjuvant chemotherapy. Pathology, histology, and immunohistochemistry results were compared between CNB specimens and excisional biopsy. Upward and downward tendencies could be observed in CNB specimens and excisional biopsy, respectively, in all items. Tumor proportion of CNB tissues was (33 + 2)/45 = 77.78%, when ductal carcinoma in situ detected by both CNB and excisional biopsy was 31/45 = 68.89%, with a consistency of (31 + 3)/45 = 75.56%. Tumor thrombus detected by both CNB and excisional biopsy was 2/45 = 4.44%. Among cases receiving neoadjuvant chemotherapy, CNB and excisional biopsy, in mitotic figure, cytological scoring and histological grading, showed a total change rate of >50% (50%-75%), while changes in duct and cellular heteromorphism were not distinct. Cases showing changes were up to 73.08%, with 8/26 = 30.77% for rise and 11/26 = 42.31% for descent. CNB could be used for preoperative diagnosis of breast neoplasm, and help to determine proper treatment regimen, thus elevating the rate of breast conserving. However, this method still has several limitations, particularly in immunohistochemical tests of human epidermal receptor protein-2. Neoadjuvant chemotherapy may influence the accuracy of CNB diagnosis.
URI http://hdl.handle.net/20.500.11897/624155
ISSN 0025-7974
DOI 10.1097/MD.0000000000026970
Indexed SCI(E)
Appears in Collections: 人民医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.